Bharat Biotech to ramp up Covaxin production to 1 billion doses a year

Hyderabad-based Bharat Biotech is planning to scale up the production capacity of its indigenously-developed Covid vaccine — Covaxin — to 1 billion doses per annum by the fourth quarter of 2021.A top Bharat Biotech official said on Thursday the company plans to use its Chiron Behring facility in Gujarat's Ankleshwar to boost capacity by another 200 million doses.